Related Experiment Video
Updated: Jan 31, 2026

In Vitro Assays to Evaluate the Migration, Invasion, and Proliferation of Immortalized Human First-trimester Trophoblast Cell Lines
Published on: March 5, 2019
MicroRNA-221 regulates osteosarcoma cell proliferation, apoptosis, migration, and invasion by targeting CDKN1B/p27
Xiao-Hui Hu1,2, Ze-Xue Zhao2, Jian Dai1,2
1Department of Orthopedics, The First Affiliated Hospital of Soochow University, Suzhou, China.
Abstract:
MicroRNAs (miRNAs, miR) are of critical importance in growth and metastasis of cancer cells; however, the underlying functions of miRNAs in osteosarcoma (OS) remain largely unknown. This study was aimed to elucidate the role of miR-221 in regulating the biological behavior of OS cells. The proliferation ability was examined by cell counting kit-8 (CCK-8) and cell cycle assay. The abilities of cell migration, invasion, and apoptosis were monitored by transwell assay and flow cytometry, respectively. The effect of miR-221 on cyclin-dependent kinase inhibitor 1B (CDKN1B) expression was evaluated by luciferase assays, real-time polymerase chain reaction, and Western blot analysis. We found that miR-221 was elevated in OS cell lines compared with the normal osteoblastic cell line. Transfection of the miR-221 inhibitor into MG63 and U-2OS cell lines obviously suppressed cell proliferation, migration, and invasion, which is accompanied with cell cycle arrest in G0/G1 phase. Furthermore, luciferase reporter assays indicated that CDKN1B is directly targeted by miR-221 in OS cells. Knockdown of CDKN1B inhibited the effects of miR-221 inhibitor, along with decreased Bax and caspase-3 and increased cyclin E, cyclin D1, Bcl-2, Snail, and Twist1 expression. The results suggested that miR-221 might act as a potentially useful target for treatment of OS.
Insights
MicroRNAs (miRNAs) are crucial in cancer. This study found that elevated miR-221 promotes osteosarcoma (OS) cell growth and metastasis, suggesting miR-221 as a potential therapeutic target for OS treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- MicroRNAs (miRNAs) play significant roles in cancer cell growth and metastasis.
- The specific functions of miRNAs in osteosarcoma (OS) are not fully understood.
- Investigating novel molecular targets is crucial for effective OS treatment.
Purpose of the Study:
- To elucidate the role of miR-221 in regulating the biological behavior of osteosarcoma (OS) cells.
- To determine if miR-221 targets cyclin-dependent kinase inhibitor 1B (CDKN1B) in OS.
- To explore the potential of targeting miR-221 for OS therapy.
Main Methods:
- Cell proliferation was assessed using CCK-8 and cell cycle assays.
- Cell migration, invasion, and apoptosis were evaluated via transwell assays and flow cytometry.
- miR-221's effect on CDKN1B was analyzed using luciferase assays, real-time PCR, and Western blot.
Main Results:
- miR-221 expression was significantly higher in OS cell lines compared to normal osteoblastic cells.
- Inhibiting miR-221 suppressed OS cell proliferation, migration, and invasion, inducing G0/G1 cell cycle arrest.
- miR-221 directly targets CDKN1B, and its inhibition impacts apoptosis-related and cell cycle regulatory proteins.
Conclusions:
- miR-221 promotes proliferation, migration, and invasion in osteosarcoma cells.
- CDKN1B is a direct target of miR-221 in osteosarcoma.
- miR-221 represents a potential therapeutic target for osteosarcoma treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
Cell Migration
Cell Migration
Apoptosis
Negative Regulator Molecules

